Press kits
This information is intended for healthcare journalists, analysts and investors.
Pharmaceutical resources
ANORO™ ELLIPTA™
Press release
April 28, 2014
Anoro™ Ellipta® now available in the US for treatment of COPD
Full prescribing information
ANORO™ ELLIPTA™ (umeclidinium, vilanterol) Full Prescribing InformationPDF - 766.8KBMultimedia
ANORO™ ELLIPTA™ Product Photo Side Closed 62.5mcg/25mcgJPG - 49.9KB ANORO™ ELLIPTA™ Product Photo Front Closed 62.5mcg/25mcgJPG - 49.6KB ANORO™ ELLIPTA™ Product Photo Front Open 62.5mcg/25mcJPG - 97.5KB Back to topArnuity™ Ellipta® & Incruse® Ellipta®
Press release
January 26, 2015
GSK expands its portfolio of medicines in the US for patients with asthma and COPD
Multimedia
Arnuity™ Ellipta® 200 mcg JPG - 41.5KB Arnuity™ Ellipta® 100 mcgJPG - 41.5KB Incruse® Ellipta® Closed 62.5 mcgPNG - 8.6MB Incruse® Ellipta® Open 62.5 mcg JPG - 49.6KB Back to topBREO® ELLIPTA™
Press release
October 30, 2013
BREO® ELLIPTA™ now available in the U.S. for the treatment of COPD
Full prescribing information
BREO ELLIPTA Full US Prescribing InformationPDF - 1.1MBMultimedia
BREO ELLIPTA Product Photo Inhaler OpenPNG - 796.2KB BREO ELLIPTA Product Photo Carton + Inhaler OpenPNG - 1.2MB BREO ELLIPTA Product Photo Carton + Inhaler ClosedPNG - 1.0MB Back to topNUCALA® (mepolizumab)
Press release
November 4, 2015
GSK’s Nucala® (mepolizumab) receives approval from US FDA
Full prescribing information
NUCALA® (mepolizumab) Full Prescribing Information PDF - 249.4KBInfographics
Role of the eosinophil in severe asthmaJPG - 485.5KBMultimedia
NUCALA® (mepolizumab) 100mg Carton Product PhotoPNG - 6.0MB NUCALA® (mepolizumab) 100mg Carton & Vial Product PhotPNG - 5.9MB NUCALA® (mepolizumab) 100mg Vial Product PhotoPNG - 295.3KB Back to topThe IMPACT study: InforMing the PAthway of COPD Treatment
Press release
September 20, 2017
GSK and Innoviva report positive headline results from IMPACT study showing single inhaler triple therapy Trelegy Ellipta reduced COPD exacerbations
Multimedia
IMPACT Study infographicPDF - 267.1KB Back to topTrelegy Ellipta
Press releases
April 24, 2018
Once-daily Trelegy Ellipta gains expanded indication in the US for the treatment of patients with COPD
April 18, 2018
Landmark IMPACT study published in NEJM shows significant benefits of Trelegy Ellipta for patients with COPD
September 18, 2017
Trelegy ELLIPTA approved as the first once-daily single inhaler triple therapy for the treatment of appropriate patients with COPD in the US
Full prescribing information
Trelegy ELLIPTA Full Prescribing InformationPDF - 873.4KBMultimedia
Trelegy ELLIPTA FactsheetPDF - 164.9KB GSK Commitment to COPD CarePDF - 374.5KB Trelegy ELLIPTA Product Photo Cap ClosedPNG - 16.9MB Trelegy ELLIPTA Product Photo Cap OpenPNG - 377.1KB Trelegy IMPACT study infographicPDF - 365.8KB
Back to top
Vaccine resources
FLULAVAL QUADRIVALENT and FLUARIX QUADRIVALENT
Full US prescribing information
FLULAVAL QUADRIVALENT Full US Prescribing InformationPDF - 379.1KB FLUARIX QUADRIVALENT Full US Prescribing InformationPDF - 561.3KBMultimedia
FLULAVAL QUADRIVALENT 0.5mL dose packagingPNG - 369.9KB FLULAVAL QUADRIVALENT 5mL vial packagingPNG - 333.2KB FLUARIX QUADRIVALENT 0.5mL dose packagingPNG - 1.1MB Back to topInfluenza resources
Multimedia
Help Protect Yourself and Others Against the FluPDF - 270.6KBFor more information about flu, visit flu.gsk.com.
Back to topShingles resources
Shingrix
Press release
Date
Shingrix approved in the US for prevention of shingles in adults aged 50 and over
Multimedia
Shingrix multi-dose box and vialsJPG - 175.2KB Shingrix single-dose box and vials 1JPG - 173.9KB Shingrix single-dose box and vials 2 JPG - 189.2KB Shingrix media fact sheet PDF - 209.0KB Adjuvants and Waning Adult Immunity - media infographicPDF - 332.9KB Back to topVaccinate for Life
Press release
November 14, 2017
New survey shines light on critical gaps in adult vaccination knowledge
Executive summary
Vaccinate for Life executive summaryPDF - 313.2KBInfographic
Vaccinate for Life infographic PDF - 327.0KB Back to topGeneral resources
Partnership to Help Communities Protect and Care for Children Impacted by Disasters
Press release
June 11, 2015
Partnership to help communities protect and care for children impacted by disasters
